Y W Li

ORCID: 0000-0003-4854-9118
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Viral-associated cancers and disorders
  • Lymphoma Diagnosis and Treatment
  • Anorectal Disease Treatments and Outcomes
  • Pelvic floor disorders treatments
  • Immune Cell Function and Interaction
  • Hemoglobinopathies and Related Disorders
  • Enhanced Recovery After Surgery
  • Immunodeficiency and Autoimmune Disorders
  • Gastrointestinal motility and disorders
  • Neonatal Health and Biochemistry
  • Ginseng Biological Effects and Applications
  • Intestinal Malrotation and Obstruction Disorders
  • Cytomegalovirus and herpesvirus research
  • Biological and pharmacological studies of plants
  • Hernia repair and management
  • Parvovirus B19 Infection Studies
  • Phytochemistry and Biological Activities
  • Metabolism and Genetic Disorders
  • Eosinophilic Disorders and Syndromes

Dali University
2025

The Affiliated Yongchuan Hospital of Chongqing Medical University
2024

Chongqing Medical University
2021-2024

Jiangnan University
2024

Tianjin People's Hospital
2020-2023

Two rare C14-C15 chemical bond-breaking 7/5/5 skeleton schinortriterpenoids (SNTs), Wuweizinortriters A and B (1-2) were successfully isolated from the ethanol extracts of leaves stems Schisandra chinensis., determination their structures was achieved by using NMR, MS, UV, carbon spectrum calculation. (25 μM) moderately protected PC12 cells CORT-induced apoptosis, with viability increasing 18.02% 20.33% respectively, compared to model group.

10.1080/14786419.2025.2481609 article EN Natural Product Research 2025-03-23

Epstein-Barr virus (EBV) infects over 95% of the global population and is strongly associated with various autoimmune diseases. Anti-nuclear antibodies (ANA) serve as valuable laboratory biomarkers for screening supporting diagnosis The aim this study was to assess prevalence EBV infection its association ANA. This retrospective employed standard indirect immunofluorescence assay determine ANA levels, EBV-specific assay, or plasma EBV-DNA testing. Demographic data including gender age were...

10.1097/md.0000000000039233 article EN cc-by-nc Medicine 2024-08-09

The Epstein-Barr virus (EBV) is responsible for a spectrum of human diseases and demonstrates considerable prevalence among various populations. Advances in molecular epidemiological research have enhanced our comprehension EBV-related pathologies. In this study, objective was to examine the profile clinical features EBV infection Chongqing, China. We enrolled patients suspected who were admitted First Affiliated Hospital Chongqing Medical University between May 2013 November 2022. Inclusion...

10.1002/jmv.29960 article EN Journal of Medical Virology 2024-10-01

10.4236/abb.2024.1510039 article EN Advances in Bioscience and Biotechnology 2024-01-01

Fecal incontinence is a refractory disease in colorectal surgery. The main clinical manifestation that patients cannot control the discharge of gas, solid or liquid feces rectum autonomously. It easy to bring shame and seriously affect their physical mental health. Reducing frequency fecal incontinence, restoring anal sphincter function, improving patient quality life are important goals for treating incontinence. With development medical technology improvement treatment plans with usually...

10.3760/cma.j.cn441530-20230908-00083 article EN PubMed 2023-12-25

10.1007/s10151-020-02181-1 article EN Techniques in Coloproctology 2020-03-04

Objective: To analyze the clinical characteristics of congenital agammaglobulinemia and efficacy intravenous immunoglobulin (IVIG) replacement therapy for this disease. Methods: The basic characteristics, manifestations, laboratory examinations, outcomes 114 patients with diagnosed in Children's Hospital Chongqing Medical University from January 1988 to April 2020 were retrospectively analyzed. IVIG improving symptoms between regular irregular treatment groups compared by χ2 test. explore...

10.3760/cma.j.cn112140-20201016-00950 article EN Zhonghua erke zazhi 2021-06-02
Coming Soon ...